How autophagy machinery is used by viruses for their replication.
How autophagy machinery is used by viruses for their replication.
批准号:
RGPIN-2019-06932
负责人:
Labonté, Patrick
金额:
$2.33万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Autophagy is a highly evolutionarily conserved process present in all eukaryotic cells. It involves the sequestration of regions of cytosol within double-membrane vesicles and delivery of the contents to lysosomes for degradation and recycling of the material. Recent advances on autophagy has demonstrated that it also plays an important role in antiviral host defence. However, despite its antiviral properties, several viruses have evolved to exploit autophagy or autophagy-related proteins to promote their own replication. To persist within the cell, many of the viruses that benefit from autophagy have developed strategies to successfully escape its antiviral activity. Importantly, the mechanisms used by viruses to subvert autophagy seem to be extremely diversified. A better comprehension of the strategies utilized by viruses to subvert autophagy will provide information on the co-evolution of both, virus and autophagy. Previously, we and others have clearly demonstrated that autophagy is strongly activated upon infection with several very divergent viruses including hepatitis B and C virus (HBV, HCV), morbillivirus and Zika virus. Indeed for these viruses, activation of autophagy favours viral replication while depletion of autophagy proteins impairs viral replication. Therefore, using HCV as a model, we propose to carry on our ongoing research on autophagy with the following aim: Identification of the strategies used by viruses to manipulate the autophagy machinery for their benefit. Objectives: i)Define the function of LC3B and its homologs in the membranous web formation and viral replication in HCV-infected cells. ii)Define how the autophagy machinery contributes to the formation of HCV replication site. Recently, we demonstrate that the proviral effect of autophagy on HCV replication was due to the direct involvement of the autophagy elongation complex (ATG5-12/16) in the formation of the HCV-induced membranous web that harbour the replication complex (RC). Strikingly, the presence of ATG5-12/16 at RC does not trigger LC3B accumulation at this site nor the degradation of viral structures. Since there is six LC3 homologs in mammalian cells, the participation of these homologs in HCV-induced membranous web formation and HCV replication will be characterized. Until now, our results demonstrated that HCV does not require the autophagy process but instead hijacks the autophagy machinery for the proper formation of its replication sites. How HCV avoid the degradative process of autophagy and how the autophagy machinery help HCV replication site formation will be studied. Many very divergent viruses have evolved to subvert autophagy for their own benefit. Using an evolutionary process, they managed to turn a genuinely antimicrobial process into a proviral process. Using HCV as a model of an enveloped positive-stranded RNA virus, we will decipher the host-virus interplay that coordinates the autophagy process in infected cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification and characterization of the human factors targeted by the Nucleic Acid Polymers (NAP) responsible for its antiviral activity against HBV and HDV.
-
批准号:558342-2020
-
项目类别:Alliance Grants
-
资助金额:$3.31万
-
财政年份:2021
-
负责人:Labonté, Patrick
-
依托单位:
How autophagy machinery is used by viruses for their replication.
-
批准号:RGPIN-2019-06932
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.33万
-
财政年份:2021
-
负责人:Labonté, Patrick
-
依托单位:
Identification and characterization of the human factors targeted by the Nucleic Acid Polymers (NAP) responsible for its antiviral activity against HBV and HDV.
-
批准号:558342-2020
-
项目类别:Alliance Grants
-
资助金额:$3.28万
-
财政年份:2020
-
负责人:Labonté, Patrick
-
依托单位:
How autophagy machinery is used by viruses for their replication.
-
批准号:RGPIN-2019-06932
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.33万
-
财政年份:2020
-
负责人:Labonté, Patrick
-
依托单位:
How autophagy machinery is used by viruses for their replication.
-
批准号:RGPIN-2019-06932
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.33万
-
财政年份:2019
-
负责人:Labonté, Patrick
-
依托单位:
Characterization of the post-entry anti-HBV properties of nucleic acid polymers
-
批准号:508186-2016
-
项目类别:Collaborative Research and Development Grants
-
资助金额:$5.26万
-
财政年份:2018
-
负责人:Labonté, Patrick
-
依托单位:
How a positive-strand RNA virus such as HCV can subvert autophagy?
-
批准号:312225-2013
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.19万
-
财政年份:2017
-
负责人:Labonté, Patrick
-
依托单位:
Characterization of the post-entry anti-HBV properties of nucleic acid polymers
-
批准号:508186-2016
-
项目类别:Collaborative Research and Development Grants
-
资助金额:$5.44万
-
财政年份:2017
-
负责人:Labonté, Patrick
-
依托单位:
How a positive-strand RNA virus such as HCV can subvert autophagy?
-
批准号:312225-2013
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.19万
-
财政年份:2015
-
负责人:Labonté, Patrick
-
依托单位:
How a positive-strand RNA virus such as HCV can subvert autophagy?
-
批准号:312225-2013
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.19万
-
财政年份:2014
-
负责人:Labonté, Patrick
-
依托单位:
How a positive-strand RNA virus such as HCV can subvert autophagy?
-
批准号:312225-2013
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.19万
-
财政年份:2013
-
负责人:Labonté, Patrick
-
依托单位:
Characterization of the hepatitis C virus complex of replication
-
批准号:312225-2005
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.04万
-
财政年份:2010
-
负责人:Labonté, Patrick
-
依托单位:
Characterization of the hepatitis C virus complex of replication
-
批准号:312225-2005
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.04万
-
财政年份:2008
-
负责人:Labonté, Patrick
-
依托单位:
Characterization of the hepatitis C virus complex of replication
-
批准号:312225-2005
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.04万
-
财政年份:2007
-
负责人:Labonté, Patrick
-
依托单位:
Characterization of the hepatitis C virus complex of replication
-
批准号:312225-2005
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.04万
-
财政年份:2006
-
负责人:Labonté, Patrick
-
依托单位:
Characterization of the hepatitis C virus complex of replication
-
批准号:312225-2005
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.04万
-
财政年份:2005
-
负责人:Labonté, Patrick
-
依托单位:
Characterization of the hepatitis C virus complex of replication
-
批准号:315101-2005
-
项目类别:Research Tools and Instruments - Category 1 (<$150,000)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:Labonté, Patrick
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于FGL2-THBS1-Autophagy信号通路探索复方清痹片治疗
类风湿关节炎的效应及机制研究
-
批准号:2024JJ9459
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:黄上
-
依托单位:
自噬流/炎症小体失衡在新生儿缺血缺氧性脑病中的作用机制
-
批准号:82372205
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:崔德荣
-
依托单位:
SIRT2/Annexin A2/autophagy通路形成的分子机制及其在HCC细胞失巢凋亡抵抗中的作用研究
-
批准号:32300626
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:孙梁博
-
依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
-
批准号:82370988
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:经典
-
依托单位:
RNA应激颗粒的内平衡调控机制
-
批准号:32100624
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:康英锦
-
依托单位:
ESD通过调控FKBP25的非经典乙酰化促进自噬的分子机制
-
批准号:32100611
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:陈新鹏
-
依托单位:
Nek9磷酸化MCL-1调控线粒体自噬和分裂的机制与功能研究
-
批准号:32100598
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:岑旭峰
-
依托单位:
FLT3/ITD突变细胞与骨髓微环境通过 autophagy互话促发急性髓系白血病的耐药
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:余国攀
-
依托单位:
PI4P对细胞自噬的分子调控研究
-
批准号:32100599
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘浩
-
依托单位:
Fam60a-Autophagy通路调控肝再生的作用机制研究
-
批准号:82100644
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:水丽燕
-
依托单位: